<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Association of Serum γ-Glutamyltransferase Level and Incident Prehypertension in Korean Men</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Korean Academy of Medical Sciences (KAMJE)</publisher>
				<availability status="unknown"><p>Copyright Korean Academy of Medical Sciences (KAMJE)</p>
				</availability>
				<date type="published" when="2013">2013</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyejin</forename><surname>Chun</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Health Promotion Center</orgName>
								<orgName type="institution" key="instit1">Ewha Womans University Mokdong Hospital</orgName>
								<orgName type="institution" key="instit2">Ewha Womans University School of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sung</forename><forename type="middle">Keun</forename><surname>Park</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Total Healthcare Center</orgName>
								<orgName type="institution" key="instit2">Kangbuk Samsung Hospital</orgName>
								<orgName type="institution" key="instit3">Sungkyunkwan University</orgName>
								<address>
									<settlement>Seoul</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Jae-Hong</forename><surname>Ryoo</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">Kyung Hee University</orgName>
								<address>
									<settlement>Seoul</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Occupational and Environmental Medicine</orgName>
								<orgName type="institution">Bucheon Daesung Hospital</orgName>
								<address>
									<settlement>Bucheon</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">Kyung Hee University</orgName>
								<address>
									<addrLine>23 Kyungheedae-ro, Dongdaemun-gu</addrLine>
									<postCode>130-872</postCode>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Association of Serum γ-Glutamyltransferase Level and Incident Prehypertension in Korean Men</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Journal of Korean Medical Science</title>
						<title level="j" type="abbrev">J Korean Med Sci</title>
						<idno type="ISSN">1011-8934</idno>
						<idno type="eISSN">1598-6357</idno>
						<imprint>
							<publisher>Korean Academy of Medical Sciences (KAMJE)</publisher>
							<biblScope unit="volume">28</biblScope>
							<biblScope unit="issue">11</biblScope>
							<biblScope unit="page">1603</biblScope>
							<date type="published" when="2013" />
						</imprint>
					</monogr>
					<idno type="DOI">10.3346/jkms.2013.28.11.1603</idno>
					<idno type="PMID">24265522</idno>
					<idno type="PMCID">PMC3835501</idno>
					<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0063JKMS/jkms-28-1603.pdf" />
					<note type="submission">Received: 29 April 2013 Accepted: 12 September 2013</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:27+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Gamma-Glutamyltransferase, Prehypertension; Blood Pressure</keywords>
			</textClass>
			<abstract>
				<p>Several lines of evidence indicate that prehypertension is more atherogenic than normal blood pressure. Serum γ-glutamyltransferase (GGT) is known to be positively associated with prehypertensive status and the progression of hypertension. However, there have been no prospective studies of serum GGT level as a predictor of prehypertension. Apparently 13,435 healthy men (mean age 42.0 ± 6.6 yr) with normal blood pressure were included in a prospective cohort study in 2005 and were followed up to 2010 with the endpoint being incident of prehypertension. During the follow up period (median 2.80 ± 1.44 yr; actual follow-up 37,679.1 person-year), prehypertension was developed in 7,867 (58.6%) participants. Risk estimations for incident prehypertension were analyzed based on quartiles of serum GGT levels using multivariate adjusted Cox proportional hazards model. In unadjusted model, the hazard ratio for incident prehypertension for the highest 3 quartiles of baseline serum GGT level was 1.21 (1.13-1.29), 1.29 (1.21-1.38), and 1.57 (1.47-1.67) compared the lowest quartile of serum GGT level, respectively (P for trend &lt; 0.001). These associations still remained statistically significant, even after adjusting for multiple covariates. These findings indicate that increased serum GGT level is independently associated with incident prehypertension in Korean men.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Serum γ-glutamyltransferase (GGT), a plasma membranebound enzyme, has been used as a biological marker for alcohol intake or liver cell damage <ref type="bibr" target="#b0">(1)</ref><ref type="bibr" target="#b1">(2)</ref><ref type="bibr" target="#b2">(3)</ref>. However, recent studies have shown that serum GGT might be related to oxidative stress and might have a role in the pathogenesis of cardiovascular disease, diabetes mellitus, strokes and metabolic syndrome <ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref>.</p><p>In the seventh Joint national committee (JNC-7), National Heart, Lung, and Blood Institute (NHLBI) of United States presented a new diagnostic classification for blood pressure (BP) where systolic BP (SBP) is between 120-139 mmHg or diastolic BP (DBP) is between 80-89 mmHg, previously categorized as normotensive and borderline BP in the JNC-6, is now categorized as prehypertension. This is based on the study results that the risk of cerebral infarction and coronary artery disease increases in patients with SBP/DBP above 115/75 mmHg, and the risk is doubled as BP increases by 20/10 mmHg <ref type="bibr" target="#b6">(7)</ref>. In Strong Heart Study, the incidence rate of hypertension within 4 yr in prehypertensive group was 38%, and in Framingham Heart-Study, the risk of hypertension was doubled in prehypertensive group compared with normotensive group <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b8">9)</ref>. Additionally, the risk of cardiovascular disease in prehypertensive group has 1.8 times higher than that of normotensive group <ref type="bibr" target="#b9">(10)</ref>.</p><p>Recent cross-sectional studies have reported the association between serum GGT and hypertension and prehypertension prevalence <ref type="bibr" target="#b11">(11)</ref><ref type="bibr" target="#b12">(12)</ref><ref type="bibr" target="#b13">(13)</ref><ref type="bibr" target="#b14">(14)</ref><ref type="bibr" target="#b15">(15)</ref>. However, there was no prospective cohort study on the association between serum GGT and incident prehypertension. In this study, we examined the clinical association between baseline serum GGT level and incident prehypertension in Korean men.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study populations</head><p>The present study was a prospective cohort study to examine the association between serum GGT level and incident prehypertension in Korean men participating in a medical health check-up program at the Total Healthcare Center of Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea. We included in the present study only men who were normotensive at baseline. Initially, participants who had abnormal http://dx.doi.org/10.3346/jkms.2013.28.11.1603 blood pressure and participants with prehypertension and hypertension were excluded from this study. In 2005, 46,728 men who had participated in a medical health check-up program were recruited in this study. Among the 46,728 participants, 29,233 men were excluded due to the following reasons: 238 had a history of a malignancy; 323 had a history of cardiovascular disease; 3,241 were receiving antidyslipidemic medications; 19,793 and 9,591 had a baseline prehypertension and hypertension. Because some participants had more than one exclusion criteria, the total number of men who were eligible for the study was 17,495. We further excluded 4,060 participants who did not attend any follow-up visit between 2006 and 2010. Accordingly, 13,435 participants were included in the final analysis and were observed for incident prehypertension. The total follow-up period was 37,679.1 person-year and average followup period was 2.80 ± 1.44 person-years.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and Laboratory measurements</head><p>Study data included a medical history, a physical examination, information provided by a questionnaire, anthropometric measurements and laboratory measurements. The medical history was assessed by the examining physicians. All the participants were asked about health-related behavior including alcohol intake, cigarette smoking and physical activity. Questions about alcohol intake included the frequency of alcohol intake per week and the usual amount of alcohol intake per day. We considered participants as current smoker who reported to smoke at that time of the study. In addition, the participants were asked about the frequency of physical activity, such as jogging, bicycling, and swimming that lasted long enough to produce perspiration (≥ 1 time/week). Body mass index (BMI) was calculated as the weight (kilograms) divided by height (meters) squared.</p><p>After a 5-min rest, BP was measured on the right upper arm in the sitting position using a standardized mercury sphygmomanometer. SBP and DBP were recorded as the first and fifth Korotkoff phases, respectively. According to the JNC-7 guidelines, the measured BP was classified as normal (SBP &lt; 120 mmHg and a DBP &lt; 80 mmHg), prehypertension (SBP 120 to 139 mmHg or DBP 80 to 90 mmHg) and hypertension (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg, or current use of medication for hypertension). Diabetes mellitus was defined as fasting serum glucose more than 126 mg/dL, or current use of medication for diabetes.</p><p>After fasting for at least 12 hr, peripheral venous samples were collected. Total cholesterol, triglyceride, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, creatinine, high-sensitivity C-reactive protein (hs-CRP), fasting blood glucose, insulin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and GGT were measured. Serum GGT was measured using Bayer Reagent Packs (Bayer Health-Care, Tarrytown, NY, USA) on an automated chemistry analyzer (ADVIA 1650 Autoanalyzer; Bayer Diagnostics, Leverkusen, Germany). Insulin levels were measured with immunoradiometric assays (Biosource, Nivelles, Belgium). Insulin resistance was calculated with the homeostasis model assessment of insulin resistance (HOMA-IR): fasting serum insulin (μU/mL) × FBG (mg/dL)/22.5 <ref type="bibr" target="#b16">(16)</ref>. The clinical laboratory has been accredited and participates annually in inspections and surveys by the Korean Association of Quality Assurance for Clinical Laboratories.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Data in the text and tables were expressed as the mean ± standard deviation (SD) or medians (interquartile range) for continuous variables and percentages of the number for categorical variables. Participants were divided into quartiles on the basis of serum GGT level as follows: quartile 1, GGT &lt; 17 IU/L; quartile 2, GGT 17 to 25 IU/L; quartile 3, 25 to 40 IU/L GGT; and quartile 4, GGT ≥ 40 IU/L. The one-way ANOVA and chisquare-test were used to analyze the statistical differences among the characteristics of the participants at the baseline visit according to the quartile groups of serum GGT level. The distributions of continuous variables were evaluated, and log transformations were used in the analysis as required. For cases with incident prehypertension, the time spent at incident prehypertension was assumed to be the midpoint between the baseline visit and the visit at which prehypertension was first diagnosed. The person years were calculated as the sum of follow-up times from the baseline until the assumed time prehypertension was diagnosed or until the final examination of each individual. Compared to the lowest quartile of serum GGT, the hazards ratios (HRs) of the highest 3 quartiles of serum GGT was calculated by the Cox proportional hazard model after adjustment for baseline characteristics such as age, log (hsCRP), total cholesterol, creatinine, recent smoking status, alcohol intake, regular exercise and diabetes mellitus. For the linear trends of risk, the number of quartiles was used as a continuous variable and tested on each model. To use the Cox proportional hazards models, we checked the validity of the proportional hazards assumption. Two approaches were used to assess the validity of the proportional hazards assumption. First, the assumption was assessed by log-minus-log-survival function and found to graphically hold. Second, to confirm the validity of the proportional hazards assumption, time-dependent covariate analysis was used. The time-dependent covariate was not statistically significant, suggesting that the proportional hazards assumption is not violated (P = 0.055). P values less than 0.05 were considered to be statistically significant. Statistical analyses were performed PASW Statistics 18 (SPSS Inc., Chicago, IL, USA).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics statement</head><p>This cohort study was approved by the institutional review board </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>The demographic and biochemical characteristics of the study participants according to the quartile groups of serum GGT level are presented in <ref type="table" target="#tab_0">Table 1</ref>. During 37,679.1 person-years of follow-up, 7,867 (58.6%) cases of prehypertension were diagnosed between 2006 and 2010. At the baseline visit, the mean age and BMI of study participants were 42.0 ± 6.6 yr and 23.6 ± 2.6 kg/m 2 , respectively. There were significant linear trends across the quartiles of serum GGT level with respect to all of the listed variables. Age, BMI, SBP, DBP, total cholesterol, triglyceride, LDL-cholesterol, fasting blood glucose, insulin, HOMA-IR, hsCRP, AST and ALT tended to increased as the serum GGT quartile increased. The percentages of current smoker, alcohol intake participant and diabetes mellitus have a tendency to increase along with the increase of the serum GGT quartile. However, HDL-cholesterol and the percentages of regular exercise participants tended to decrease along with the increase in the serum GGT quartile, respectively. <ref type="table">Table 2</ref> shows the incident prehypertension have a tendency to increase according to the quartile groups of serum GGT level. The baseline characteristics of participants with or without incident prehypertension are shown in <ref type="table" target="#tab_1">Table 3</ref>. Participants who were diagnosed prehypertension during the follow-up period had higher serum GGT level at baseline compared with those who did not develop prehypertension. In contrast to participants without incident prehypertension, those with incident prehypertension were slightly older (42.6 vs 41.2 yr) and more likely to have a less favorable metabolic profiles at baseline. As expected, all clinical variables showed statistically significant differences between two groups except for recent smoking status. <ref type="table" target="#tab_2">Table 4</ref> presented the results of Cox proportional HRs and 95% confidence interval (CI) for prehypertension according to the quartile groups of serum GGT levels. In unadjusted model, the HRs and 95% CI for incident prehypertension for the highest 3 quartiles of baseline serum GGT level 1.21 (95% CI, 1.13-1.29), 1.29 (95% CI, 1.21-1.38) and 1.57 (95% CI, 1.47-1.67) compared to the lowest quartile of serum GGT, respectively (P for trend &lt; 0.001). The age adjusted HRs was 1.19 (95% CI, 1.12-1.27), 1.26 (95% CI, 1.18-1.34) and 1.51 (95% CI, 1.42-1.61) compared to the lowest quartile of serum GGT, respectively (P for trend &lt; 0.001). These associations still maintained statistically significant, even after further adjustments for explanatory vari-  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>Serum GGT level was found to be positively associated with the incident prehypertension in Korean men, free of baseline prehypertension, hypertension and many other diseases. The HR of prehypertension was increased with in a dose-dependent manner by increasing quartiles of serum GGT. Theses association persisted after adjusting for age, total cholesterol, log (hsCRP), creatinine, current smoking status, alcohol intake, regular exer- cise, and diabetes mellitus. In our study, 17,495 eligible male participants were selected because of sex differences in serum GGT level. Serum GGT was significantly higher in men compared to women due to the greater consumption of alcohol and higher prevalence of liver disease in men <ref type="bibr" target="#b17">(17)</ref>. Another reason was the difference in distribution of excess fat in men and women. Serum GGT in women with BMI above 32 kg/m 2 was comparable to the serum GGT in men with BMI in the range of 20-24 kg/m 2 <ref type="bibr" target="#b18">(18,</ref><ref type="bibr" target="#b19">19)</ref>.</p><p>To the best of our knowledge, our study was the first prospective cohort study demonstrating a positive association between baseline serum GGT level and incident prehypertension; therefore we were unable to compare our results with those of others. Only several previous cross-sectional studies showed that serum GGT is associated with prevalence of prehypertension. Higher serum GGT levels were associated with prehypertension in nationally representative sample of the US adults, with the multivariate odds ratio (OR) (95% CI) of 1.84 (1.37-2.46) comparing quartile 4 of serum GGT (&gt; 29 U/L) to quartile 1 (&lt; 13 U/L). Their results were consistent in subgroup analyses of race-ethnicity, age, smoking, alcohol intake, BMI, waist circumference and diabetes <ref type="bibr" target="#b13">(13)</ref>. Similar results were found in a community-based cross-sectional study from Japan and Turkey. The multivariate OR (95% CI) for prehypertension was 1.73 (1.06-3.18) for the middle tertile (29-53 IU/L) and 2.37 (1.31-4.31) for the highest tertile (&gt; 53 IU/L), compared to the lowest tertile of serum GGT (&lt; 29 IU/L) in Japanese men <ref type="bibr" target="#b14">(14)</ref>. And the mean serum GGT level was higher in the prehypertension group than in the control group (24.33 and 18.85 U/L, respectively; P &lt; 0.001) in Turkish men and women <ref type="bibr" target="#b15">(15)</ref>. These findings were consistent with previous reports related to hypertension <ref type="bibr" target="#b16">(16,</ref><ref type="bibr" target="#b20">20)</ref>. However, we further suggest that serum GGT level is also related to incident prehypertension, a stage with higher risk of progressing to hypertension. Therefore, if people who have higher serum GGT level change their life-style with the healthy behavior such as a combination of increased physical activity, moderation in alcohol intake, and consumption of a diet that is lower in sodium content and higher in fruit, vegetables, and low-fat dairy products, then risk of progressing to hypertension will be decreased <ref type="bibr" target="#b21">(21,</ref><ref type="bibr" target="#b22">22)</ref>. Prehypertension was one of the main contributors to hypertension, and possibly to the future development of cardiovascular disease, although there were differences in the progression rate prehypertension to hypertension <ref type="bibr" target="#b8">(9,</ref><ref type="bibr" target="#b23">23)</ref>. Thus, we consistently suggest that higher serum GGT level within physiologically normal range may be useful to predict the risk of prehypertension.</p><p>GGT is an enzyme expressed in serum and most cell surfaces; however the function of GGT on these cells is uncertain. Emerging evidence has been shown that serum GGT might be an important enzyme in the pathogenesis of cardiovascular diseases. However, the mechanisms by which the serum GGT level increases the risk of prehypertension are not fully understood. In our study, the serum GGT predicted the incident prehypertension independently of the alcohol intake. Therefore, the association between serum GGT and prehypertension is not mediated by alcohol intake. Several lines of recent evidence suggest that an association between serum GGT and incident prehypertension is plausible. First, serum GGT has been interpreted as a reliable marker of oxidative stress <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b5">6)</ref>. Serum GGT has a critical role in the maintenance of intracellular defense mechanism by initiating extracellular catabolism of glutathione, the main antioxidant in mammalian cells <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b24">24)</ref>. These associations suggest that GGT may be a marker of oxidative stress. Oxidative stress caused increase of BP by direct vasoconstriction and sodium retention in the vascular smooth muscle and endothelial cells (3). Second, insulin resistance could play a major role in the association between serum GGT and incident prehypertension, because GGT might be interpreted as a marker for hepatic steatosis and hepatic insulin resistance <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b4">5)</ref>. More recent studies suggest that leptin may stimulate sympathetic outflow from the hypothalamus which will increase the heart rate and BP <ref type="bibr" target="#b25">(25)</ref>. In this study, HOMA-IR increased in dose-response manner with increasing quartiles of serum GGT. Serum GGT might be a reliable predictor of diabetes and hypertension, even within a physiologically normal range in the CARDIA study <ref type="bibr" target="#b5">(6)</ref>. Third, serum GGT activity probably reflected chronic inflammation associated with low levels of anti-inflammatory hormones or cytokines. Serum GGT was strongly associated with C-reactive protein, the widely recognized marker of chronic inflammation <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b26">26)</ref>. These results strongly suggest that GGT is involved in the pathway of inflammation. However to clarify the mechanisms of prehypertension, further interventional studies that target serum GGT are needed.</p><p>Several limitations of this study must be considered. First, participants were self-selected and approximately 23% of participants were excluded because they were unattended any follow up visit. Therefore this study might posses some selection bias. Moreover, a single reading of BP on only 1 visit may have served as a drawback because of large random fluctuations in a casual reading.</p><p>In conclusion, serum GGT was an early predictor for progression of prehypertension in healthy Korean men. Therefore increased serum GGT level is implicated in increased BP and the progression of prehypertension. In addition, it is needed to determine whether a more aggressive intervention, such as nutritional or lifestyle modifications that decrease serum GGT level, will decrease the risk of prehypertension.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCLOSURE</head><p>The authors have no potential conflicts of interest to disclose.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>http://dx.doi.org/10.3346/jkms.2013.28.11.1603 Baseline characteristics of participants according to quartile groups of serum GGT level (n=13,435)</figDesc><table><row><cell>Characteristics</cell><cell>Overall</cell><cell cols="4">GGT (IU/L) Quartile 1 ( &lt; 17) Quartile 2 ( ≥ 17, &lt; 25) Quartile 3 ( ≥ 25, &lt; 40) Quartile 4 ( ≥ 40)</cell><cell>P for trend*</cell></row><row><cell>Person-year (total)</cell><cell>37,679.1</cell><cell>10,005.4</cell><cell>9,773.2</cell><cell>9,093.4</cell><cell>8,807.1</cell><cell></cell></row><row><cell>Person-year (average)</cell><cell>2.80 ± 1.44</cell><cell>3.00 ± 1.45</cell><cell>2.85 ± 1.45</cell><cell>2.77 ± 1.44</cell><cell>2.59 ± 1.41</cell><cell>&lt; 0.001</cell></row><row><cell>Age (yr)</cell><cell>42.0 ± 6.6</cell><cell>41.1 ± 6.9</cell><cell>41.7 ± 6.5</cell><cell>42.4 ± 6.6</cell><cell>42.8 ± 6.3</cell><cell>&lt; 0.001</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>23.6 ± 2.6</cell><cell>22.4 ± 2.3</cell><cell>23.2 ± 2.4</cell><cell>24.0 ± 2.5</cell><cell>24.9 ± 2.5</cell><cell>&lt; 0.001</cell></row><row><cell>Systolic BP (mmHg)</cell><cell>103.4 ± 7.1</cell><cell>102.5 ± 7.5</cell><cell>103.5 ± 7.1</cell><cell>103.7 ± 7.0</cell><cell>104.0 ± 6.7</cell><cell>&lt; 0.001</cell></row><row><cell>Diastolic BP (mmHg)</cell><cell>69.1 ± 4.4</cell><cell>68.4 ± 4.7</cell><cell>69.0 ± 4.3</cell><cell>69.3 ± 4.2</cell><cell>69.6 ± 4.2</cell><cell>&lt; 0.001</cell></row><row><cell>Total cholesterol (mg/dL)</cell><cell>189.1 ± 30.9</cell><cell>177.0 ± 27.3</cell><cell>186.2 ± 28.9</cell><cell>193.0 ± 30.2</cell><cell>200.2 ± 32.2</cell><cell>&lt; 0.001</cell></row><row><cell>Triglyceride (mg/dL)</cell><cell>113 (83-158)</cell><cell>88 (68-116)</cell><cell>104 (79-140)</cell><cell>123 (91-167)</cell><cell>150 (111-202)</cell><cell>&lt; 0.001</cell></row><row><cell>HDL-cholesterol (mg/dL)</cell><cell>50.3 ± 10.3</cell><cell>51.6 ± 10.2</cell><cell>50.4 ± 10.3</cell><cell>49.7 ± 10.3</cell><cell>49.6 ± 10.3</cell><cell>&lt; 0.001</cell></row><row><cell>LDL-cholesterol (mg/dL)</cell><cell>111.5 ± 26.2</cell><cell>103.0 ± 23.5</cell><cell>110.4 ± 25.0</cell><cell>114.5 ± 25.8</cell><cell>117.8 ± 28.0</cell><cell>&lt; 0.001</cell></row><row><cell>Fasting blood glucose (mg/dL)</cell><cell>95.3 ± 13.7</cell><cell>93.1 ± 12.5</cell><cell>94.3 ± 11.8</cell><cell>95.5 ± 12.2</cell><cell>98.4 ± 17.2</cell><cell>&lt; 0.001</cell></row><row><cell>HOMA-IR</cell><cell>1.81 (1.41-2.38)</cell><cell>1.59 (1.28-2.00)</cell><cell>1.73 (1.36-2.21)</cell><cell>1.87 (1.45-2.46)</cell><cell>2.17 (1.65-2.81)</cell><cell>&lt; 0.001</cell></row><row><cell>Insulin (µU/dL)</cell><cell>8.4 ± 3.1</cell><cell>7.4 ± 2.4</cell><cell>8.0 ± 2.7</cell><cell>8.6 ± 3.3</cell><cell>9.6 ± 3.5</cell><cell>&lt; 0.001</cell></row><row><cell>Creatinine (mg/dL)</cell><cell>1.12 ± 0.12</cell><cell>1.11 ± 0.10</cell><cell>1.12 ± 0.15</cell><cell>1.13 ± 0.10</cell><cell>1.13 ± 0.11</cell><cell>&lt; 0.001</cell></row><row><cell>hsCRP (mg/L)</cell><cell>0.05 (0.02-0.10)</cell><cell>0.03 (0.02-0.07)</cell><cell>0.04 (0.02-0.09)</cell><cell>0.05 (0.03-0.11)</cell><cell>0.07 (0.04-0.14)</cell><cell>&lt; 0.001</cell></row><row><cell>AST (U/L)</cell><cell>23 (19-27)</cell><cell>21 (18-24)</cell><cell>22 (18-25)</cell><cell>24 (20-28)</cell><cell>27 (23-33)</cell><cell>&lt; 0.001</cell></row><row><cell>ALT (U/L)</cell><cell>24 (18-33)</cell><cell>18 (15-23)</cell><cell>21 (17-27)</cell><cell>26 (20-33)</cell><cell>35 (26-49)</cell><cell>&lt; 0.001</cell></row><row><cell>Current smoker (%)</cell><cell>45.9</cell><cell>36.7</cell><cell>42.3</cell><cell>47.4</cell><cell>56.8</cell><cell>&lt; 0.001</cell></row><row><cell>Alcohol intake (%)</cell><cell>9.2</cell><cell>4.1</cell><cell>6.1</cell><cell>9.6</cell><cell>16.8</cell><cell>&lt; 0.001</cell></row><row><cell>Regular exercise (%)</cell><cell>13.4</cell><cell>15.1</cell><cell>13.6</cell><cell>13.4</cell><cell>11.4</cell><cell>&lt; 0.001</cell></row><row><cell>Diabetes mellitus (%)</cell><cell>2.3</cell><cell>1.1</cell><cell>1.5</cell><cell>2.5</cell><cell>3.9</cell><cell>&lt; 0.001</cell></row><row><cell></cell><cell></cell><cell></cell><cell>GGT (IU/L)</cell><cell></cell><cell cols="2">Incident of prehypertension (%)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Quartile 1 ( &lt; 17)</cell><cell></cell><cell>51.0</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Quartile 2 ( ≥ 17, &lt; 25)</cell><cell>57.8</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Quartile 3 ( ≥ 25, &lt; 40)</cell><cell>59.6</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Quartile 4 ( ≥ 40)</cell><cell></cell><cell>65.7</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>P for trend*</cell><cell></cell><cell>&lt; 0.001</cell><cell></cell></row></table><note>Data are means (standard deviation), medians (interquartile range), or percentages. *P value by ANOVA for continuous variables and chi square test for categorical variables. Table 2. Incident prehypertension according to quartile groups of serum GGT level*P value by chi square test for categorical variables.of Kangbuk Samsung Hospital (Seoul, Korea) (IRB number: KBC12134). Informed consent was obtained from all partici- pants.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 3 .</head><label>3</label><figDesc>Comparison between participants with and without incident of prehypertension</figDesc><table><row><cell>Characteristics</cell><cell>Without incident of prehypertension (n = 5,568)</cell><cell>With incident of prehypertension (n = 7,867)</cell><cell>P value*</cell></row><row><cell>Age (yr)</cell><cell>41.2 ± 6.6</cell><cell>42.6 ± 6.5</cell><cell>&lt; 0.001</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>23.2 ± 2.5</cell><cell>23.9 ± 2.6</cell><cell>&lt; 0.001</cell></row><row><cell>Systolic BP (mmHg)</cell><cell>102.2 ± 7.3</cell><cell>104.3 ± 6.8</cell><cell>&lt; 0.001</cell></row><row><cell>Diastolic BP (mmHg)</cell><cell>68.3 ± 4.7</cell><cell>69.6 ± 4.1</cell><cell>&lt; 0.001</cell></row><row><cell>Total cholesterol (mg/dL)</cell><cell>187.0 ± 30.8</cell><cell>190.7 ± 30.9</cell><cell>&lt; 0.001</cell></row><row><cell>Triglyceride (mg/dL)</cell><cell>123.5 ± 69.3</cell><cell>135.3 ± 73.5</cell><cell>&lt; 0.001</cell></row><row><cell>HDL-cholesterol (mg/dL)</cell><cell>50.7 ± 10.4</cell><cell>50.0 ± 10.2</cell><cell>&lt; 0.001</cell></row><row><cell>LDL-cholesterol (mg/dL)</cell><cell>110.0 ± 26.3</cell><cell>112.6 ± 26.1</cell><cell>&lt; 0.001</cell></row><row><cell>Fasting blood glucose (mg/dL)</cell><cell>94.3 ± 12.3</cell><cell>96.1 ± 14.6</cell><cell>&lt; 0.001</cell></row><row><cell>HOMA-IR</cell><cell>1.90 ± 0.80</cell><cell>2.04 ± 0.87</cell><cell>&lt; 0.001</cell></row><row><cell>Insulin (µU/dL)</cell><cell>8.1 ± 3.0</cell><cell>8.6 ± 3.2</cell><cell>&lt; 0.001</cell></row><row><cell>Creatinine (mg/dL)</cell><cell>1.12 ± 0.1</cell><cell>1.13 ± 0.1</cell><cell>&lt; 0.001</cell></row><row><cell>hsCRP (mg/L)</cell><cell>0.11 ± 0.3</cell><cell>0.13 ± 0.4</cell><cell>&lt; 0.001</cell></row><row><cell>AST (U/L)</cell><cell>24.1 ± 14.6</cell><cell>25.4 ± 15.1</cell><cell>&lt; 0.001</cell></row><row><cell>ALT (U/L)</cell><cell>26.9 ± 23.7</cell><cell>29.7 ± 24.3</cell><cell>&lt; 0.001</cell></row><row><cell>GGT (IU/L)</cell><cell>31.4 ± 28.2</cell><cell>37.1 ± 34.6</cell><cell>&lt; 0.001</cell></row><row><cell>Current smoker (%)</cell><cell>46.0</cell><cell>45.8</cell><cell>0.855</cell></row><row><cell>Alcohol intake (%)</cell><cell>8.1</cell><cell>9.9</cell><cell>&lt; 0.001</cell></row><row><cell>Regular exercise (%)</cell><cell>12.1</cell><cell>14.3</cell><cell>&lt; 0.001</cell></row><row><cell>Diabetes mellitus (%)</cell><cell>1.9</cell><cell>2.5</cell><cell>0.019</cell></row></table><note>http://dx.doi.org/10.3346/jkms.2013.28.11.1603Data are expressed as means (standard deviation) or percentages. *P value by t-test for continuous variables and chi square test for categorical variables.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 4 .</head><label>4</label><figDesc>Hazard ratios (HRs) and 95% confidence intervals (CI) for incident of prehypertension according to quartile groups of serum GGT level</figDesc><table><row><cell>Variables</cell></row></table><note></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>http://dx.doi.org/10.3346/jkms.2013.28.11.1603</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Gamma Glutamyl Transferase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Whitfield</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Gamma Glutamyltransferase</surname></persName>
		</author>
		<idno type="DOI">10.1080/20014091084227</idno>
		<idno type="PMID">11563810</idno>
	</analytic>
	<monogr>
		<title level="j">Critical Reviews in Clinical Laboratory Sciences</title>
		<title level="j" type="abbrev">Critical Reviews in Clinical Laboratory Sciences</title>
		<idno type="ISSN">1040-8363</idno>
		<idno type="ISSNe">1549-781X</idno>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="263" to="355" />
			<date type="published" when="2001-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Gamma-Glutamyl Transpeptidase-Dependent Lipid Peroxidation in Isolated Hepatocytes and HepG2 Hepatoma Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aldo</forename><surname>Paolicchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Tongiani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrizia</forename><surname>Tonarelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><surname>Comporti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alfonso</forename><surname>Pompella</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0891-5849(96)00422-4</idno>
		<idno type="PMID">9119254</idno>
		<idno type="PII">S0891-5849(96)00422-4</idno>
		<idno type="ark">ark:/67375/6H6-8Z8155LM-2</idno>
		<idno type="istexId">F60211046557B97216F671508032A1BEE6E9942C</idno>
	</analytic>
	<monogr>
		<title level="j">Free Radical Biology and Medicine</title>
		<title level="j" type="abbrev">Free Radical Biology and Medicine</title>
		<idno type="ISSN">0891-5849</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="853" to="860" />
			<date type="published" when="1997-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Duk-Hee</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rune</forename><surname>Blomhoff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">R</forename><surname>Jacobs</surname></persName>
		</author>
		<idno type="DOI">10.1080/10715760410001694026</idno>
		<idno type="PMID">15346644</idno>
		<ptr type="open-access" target="http://folk.uio.no/runeb/pdf filer/Duk-Hee Lee et al FFR 2004.pdf" />
	</analytic>
	<monogr>
		<title level="j">Free Radical Research</title>
		<title level="j" type="abbrev">Free Radical Research</title>
		<idno type="ISSN">1071-5762</idno>
		<idno type="ISSNe">1029-2470</idno>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="535" to="539" />
			<date type="published" when="2004-06" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D-H</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Silventoinen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Jacobs</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Jousilahti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sundvall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Tuomilehto</surname></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehl086</idno>
		<idno type="PMID">16772340</idno>
		<ptr type="open-access" target="https://academic.oup.com/eurheartj/article-pdf/27/18/2170/9624554/ehl086.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Heart Journal</title>
		<title level="j" type="abbrev">European Heart Journal</title>
		<idno type="ISSN">0195-668X</idno>
		<idno type="ISSNe">1522-9645</idno>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="2170" to="2176" />
			<date type="published" when="2006-08-09" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">W</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Albano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>D'agostino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">S</forename><surname>Vasan</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.atv.0000251993.20372.40</idno>
		<idno type="PMID">17095717</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.0000251993.20372.40" />
	</analytic>
	<monogr>
		<title level="j">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<title level="j" type="abbrev">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<idno type="ISSN">1079-5642</idno>
		<idno type="ISSNe">1524-4636</idno>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="127" to="133" />
			<date type="published" when="2007-01-01" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D-H</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Jacobs</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">I</forename><surname>Kiefe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Roseman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">E</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Steffes</surname></persName>
		</author>
		<idno type="DOI">10.1373/49.8.1358</idno>
		<idno type="PMID">12881453</idno>
		<ptr type="open-access" target="http://clinchem.aaccjnls.org/content/49/8/1358.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Chemistry</title>
		<title level="j" type="abbrev">Clinical Chemistry</title>
		<idno type="ISSN">0009-9147</idno>
		<idno type="ISSNe">1530-8561</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1358" to="1366" />
			<date type="published" when="2003-08-01" />
			<publisher>American Association for Clinical Chemistry (AACC)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">V</forename><surname>Chobanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">L</forename><surname>Bakris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">R</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Cushman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Izzo</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Materson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Oparil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Wright</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Roccella</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.0000107251.49515.c2</idno>
		<idno type="PMID">14656957</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.0000107251.49515.c2" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1206" to="1252" />
			<date type="published" when="2003-12-01" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Cardiovascular and Metabolic Predictors of Progression of Prehypertension Into Hypertension: The Strong Heart Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>De Marco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>De Simone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Chinali</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">V</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Devereux</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.109.129031</idno>
		<idno type="PMID">19720957</idno>
		<idno type="PMCID">PMC2776057</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.109.129031" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="974" to="980" />
			<date type="published" when="2009-08-31" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ramachandran</forename><forename type="middle">S</forename><surname>Vasan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">G</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><forename type="middle">P</forename><surname>Leip</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">B</forename><surname>Kannel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Levy</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(01)06710-1</idno>
		<idno type="PMID">11728544</idno>
		<idno type="PII">S0140-6736(01)06710-1</idno>
		<idno type="ark">ark:/67375/6H6-HMSS3MH7-N</idno>
		<idno type="istexId">A21A5DF4EF082ED00B55A3197527761A166A35F4</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="issue">9294</biblScope>
			<biblScope unit="page" from="1682" to="1686" />
			<date type="published" when="2001-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample: The Strong Heart Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Devereux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">G</forename><surname>Best</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">R</forename><surname>Fabsitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">V</forename><surname>Howard</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.0000205119.19804.08</idno>
		<idno type="PMID">16446387</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.0000205119.19804.08" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="410" to="414" />
			<date type="published" when="2006-01-30" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study</title>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="410" to="414" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Alcohol, high blood pressure, and serum gamma-glutamyl transpeptidase level.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ishizaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Tsuritani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ikai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Yamaya</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.18.6.819</idno>
		<idno type="PMID">1683858</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.18.6.819" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="819" to="826" />
			<date type="published" when="1991-12" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The Tromsø Study: distribution and population determinants of gamma-glutamyltransferase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Nilssen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><forename type="middle">H</forename><surname>Førde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Brenn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="318" to="344" />
			<date type="published" when="1990" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Association Between Serum Gamma-Glutamyltransferase Level and Prehypertension Among US Adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anoop</forename><surname>Shankar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jialiang</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1253/circj.71.1567</idno>
		<idno type="PMID">17895553</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/circj/71/10/71_10_1567/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Circulation Journal</title>
		<title level="j" type="abbrev">Circ J</title>
		<idno type="ISSN">1346-9843</idno>
		<idno type="ISSNe">1347-4820</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1567" to="1572" />
			<date type="published" when="2007" />
			<publisher>Japanese Circulation Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Association between Serum Gamma-Glutamyl Transferase Level and Prehypertension among Community-Dwelling Men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryuichi</forename><surname>Kawamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katsuhiko</forename><surname>Kohara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuharu</forename><surname>Tabara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomo</forename><surname>Kusunoki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuyuki</forename><surname>Otsuka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuro</forename><surname>Miki</surname></persName>
		</author>
		<idno type="DOI">10.1620/tjem.216.213</idno>
		<idno type="PMID">18987455</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/tjem/216/3/216_3_213/_pdf" />
	</analytic>
	<monogr>
		<title level="j">The Tohoku Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">Tohoku J. Exp. Med.</title>
		<idno type="ISSN">0040-8727</idno>
		<idno type="ISSNe">1349-3329</idno>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="213" to="221" />
			<date type="published" when="2008" />
			<publisher>Tohoku University Medical Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Gamma-glutamyltransferase activity increases in prehypertensive patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Karakurt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Cagirici</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">E</forename><surname>Eryasar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Turk J Med Sci</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="975" to="80" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Hosker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Rudenski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Naylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">F</forename><surname>Treacher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C</forename><surname>Turner</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00280883</idno>
		<idno type="PMID">3899825</idno>
		<idno type="ark">ark:/67375/1BB-X4N5RJTK-0</idno>
		<idno type="istexId">9DC9D3442DA175B4FA5530929CF05BE75D903223</idno>
		<ptr type="open-access" target="https://link.springer.com/content/pdf/10.1007%2FBF00280883.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<title level="j" type="abbrev">Diabetologia</title>
		<idno type="ISSN">0012-186X</idno>
		<idno type="ISSNe">1432-0428</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="412" to="419" />
			<date type="published" when="1985-07" />
			<publisher>Springer Nature America, Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Sex differences in gamma-glutamyltransferase in people aged 40–42 years in two Norwegian counties</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Svetlana</forename><surname>Skurtveit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aage</forename><surname>Tverdal</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0376-8716(02)00015-7</idno>
		<idno type="PMID">12062783</idno>
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Dependence</title>
		<title level="j" type="abbrev">Drug and Alcohol Dependence</title>
		<idno type="ISSN">0376-8716</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="95" to="98" />
			<date type="published" when="2002-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franco</forename><surname>Pintus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrizia</forename><surname>Mascia</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00144431</idno>
		<idno type="PMID">8817181</idno>
		<idno type="ark">ark:/67375/1BB-760Q8BSK-1</idno>
		<idno type="istexId">23A46565B260559507E88C5FCD32EE5E46791DC4</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Epidemiology</title>
		<title level="j" type="abbrev">Eur J Epidemiol</title>
		<idno type="ISSN">0392-2990</idno>
		<idno type="ISSNe">1573-7284</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="71" to="76" />
			<date type="published" when="1996-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Brief Communication: Clinical Implications of Short-Term Variability in Liver Function Test Results</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mariana</forename><surname>Lazo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elizabeth</forename><surname>Selvin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeanne</forename><forename type="middle">M</forename><surname>Clark</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-148-5-200803040-00005</idno>
		<idno type="PMID">18316753</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Internal Medicine</title>
		<title level="j" type="abbrev">Ann Intern Med</title>
		<idno type="ISSN">0003-4819</idno>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">348</biblScope>
			<date type="published" when="2008-03-04" />
			<publisher>American College of Physicians</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Serum gamma-glutamyltransferase level in predicting hypertension among male drinkers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Miura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tabata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Nagase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kawano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hum Hypertens</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="445" to="454" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Progression to hypertension in the non-hypertensive participants in the Flemish Study on Environment, Genes and Health Outcomes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haifeng</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lutgarde</forename><surname>Thijs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tatiana</forename><surname>Kuznetsova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">H</forename><surname>Fagard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xinli</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jan</forename><forename type="middle">A</forename><surname>Staessen</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.hjh.0000242395.07473.92</idno>
		<idno type="PMID">16915020</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Hypertension</title>
		<title level="j" type="abbrev">Journal of Hypertension</title>
		<idno type="ISSN">0263-6352</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1719" to="1727" />
			<date type="published" when="2006-09" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Primary Prevention of Hypertension&lt;SUBTITLE&gt;Clinical and Public Health Advisory From the National High Blood Pressure Education Program&lt;/SUBTITLE&gt;</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Appel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Cutler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Havas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Kotchen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Roccella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Stout</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Vallbona</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Winston</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.288.15.1882</idno>
		<idno type="PMID">12377087</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<title level="j" type="abbrev">JAMA</title>
		<idno type="ISSN">0098-7484</idno>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page">1882</biblScope>
			<date type="published" when="2002-10-16" />
			<publisher>American Medical Association (AMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">From “Prehypertension” to Hypertension? Additional Evidence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">R</forename><surname>Winegarden</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.annepidem.2005.02.010</idno>
		<idno type="PMID">15921930</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Epidemiology</title>
		<title level="j" type="abbrev">Annals of Epidemiology</title>
		<idno type="ISSN">1047-2797</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="720" to="725" />
			<date type="published" when="2005-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Analysis of glutathione: implication in redox and detoxification</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anna</forename><surname>Pastore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giorgio</forename><surname>Federici</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Enrico</forename><surname>Bertini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fiorella</forename><surname>Piemonte</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0009-8981(03)00200-6</idno>
		<idno type="PMID">12809732</idno>
	</analytic>
	<monogr>
		<title level="j">Clinica Chimica Acta</title>
		<title level="j" type="abbrev">Clinica Chimica Acta</title>
		<idno type="ISSN">0009-8981</idno>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="19" to="39" />
			<date type="published" when="2003-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">CARDIOVASCULAR CONSEQUENCES OF OBESITY: ROLE OF LEPTIN</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">G</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donald</forename><forename type="middle">A</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">A</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">I</forename><surname>Sivitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allyn</forename><forename type="middle">L</forename><surname>Mark</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1440-1681.1998.tb02147.x</idno>
		<idno type="PMID">9493562</idno>
		<idno type="ark">ark:/67375/WNG-PH2QRFF1-F</idno>
		<idno type="istexId">3B6F21484D44C2595E113E702E17FC6FEFF72F28</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical and Experimental Pharmacology and Physiology</title>
		<title level="j" type="abbrev">Clin Exp Pharmacol Physiol</title>
		<idno type="ISSN">0305-1870</idno>
		<idno type="ISSNe">1440-1681</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="65" to="69" />
			<date type="published" when="1998-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Association between serum gamma-glutamyltransferase and C-reactive protein</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Duk-Hee</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">R</forename><surname>Jacobs</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.atherosclerosis.2004.08.027</idno>
		<idno type="PMID">15694941</idno>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<title level="j" type="abbrev">Atherosclerosis</title>
		<idno type="ISSN">0021-9150</idno>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="327" to="330" />
			<date type="published" when="2005-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
